South Korea MFDS Registry: Risk Class, Imports, and Sponsor Concentration

South Korea is one of the largest and most sophisticated medical device markets in the Asia-Pacific region. For global manufacturers, understanding the landscape of approved products in the country is crucial for competitive benchmarking and market entry strategies. In South Korea, all medical devices and in vitro diagnostics (IVDs) are regulated by the Ministry of Food and Drug Safety (MFDS) under the Medical Devices Act.

This article provides an empirical, data-driven analysis of the official MFDS medical device registry, examining the active volume of registrations, risk class distributions, import dependency, and sponsor concentration.

active registrations overview

An analysis of the MFDS medical device registry reveals a total of 273,672 historical registration records. However, medical device approvals are dynamic, with products being canceled, expired, or transferred over time.

When filtered for active, non-canceled registrations (excluding canceled, expired, or withdrawn licenses), there are exactly 136,487 active medical device registrations in South Korea.

[Active Licenses] ──────────────────────────────────────── 136,487 (49.9%)
[Withdrawn/Canceled] ───────────────────────────────────── 137,185 (50.1%)
Total Historical Registry: 273,672 records

Data Source: South Korea MFDS Medical Device Database extract, dated 2026-06-05. Active is defined as cancel_yn = "N" and item_state = "정상".

Risk Class (Grade) Distribution

The MFDS classifies medical devices into four risk-based categories (Grades 1 to 4), aligned with international GHTF/IMDRF principles. The active registry breaks down as follows across these grades:

• Grade 1 (Lowest Risk): 77,703 devices (56.9% of active registry)
  • Examples: General purpose splints, compression bandages, manually-operated surgical retractors.
• Grade 2 (Moderate Risk): 39,038 devices (28.6% of active registry)
  • Examples: Hearing aids, contact lenses, electronic endoscopes, diagnostic ultrasound transducers.
• Grade 3 (High Risk): 13,700 devices (10.0% of active registry)
  • Examples: Endosseous dental implants, orthopedic screws, transient catheters.
• Grade 4 (Highest Risk): 6,046 devices (4.4% of active registry)
  • Examples: Pacemakers, implantable defibrillators, coronary stents, active biofluid monitors.

The risk distribution follows a classic regulatory pyramid. Grade 1 devices make up more than half of the registry due to simplified notification pathways. In contrast, Grade 3 and Grade 4 devices comprise only 14.4% of active approvals due to stringent requirements, including technical file reviews, clinical data submissions, and mandatory KGMP quality system audits.

High Dependency on Imported Devices

A pivotal finding from the registry analysis is South Korea's significant reliance on foreign medical technologies. By segmenting the active approvals by license type, we can observe the ratio of imported versus domestic products:

• Imported Products (General Importers + IVD Importers): 76,208 registrations (55.8%)
  • General Imports (수입업): 65,217
  • IVD Imports (체외진단수입업): 10,991
• Domestic Products (General Manufacturers + IVD Manufacturers): 60,100 registrations (44.0%)
  • General Domestic (제조업): 51,705
  • IVD Domestic (체외진단제조업): 8,395
  • Other (conditional/pending): 179

Imports account for the majority of approved medical devices in the Korean market. While domestic Korean manufacturers are highly competitive in dental implants (e.g., Osstem) and basic diagnostics, high-end therapeutic devices, complex surgical robotics, and advanced imaging systems are heavily imported from countries like the United States, Germany, and Japan.

Local Sponsor and License Holder Concentration

Foreign manufacturers cannot hold an MFDS registration directly; they must register their devices through a licensed South Korean entity acting as the local license holder (often referred to as the local sponsor or importer of record).

An analysis of sponsor concentration shows that the top 10 license holders control 12,585 active registrations, representing 9.2% of the entire active medical device registry.

Note: The counts below reflect active registrations (cancel_yn = N, item_state = 정상) only — the current, in-market portfolio of each sponsor. For a complementary analysis of total historical holdings by licence holder and Class III/IV import concentration by source country, see our Korea MFDS import licence holder concentration analysis.

The data highlights a bifurcated market. In specialized segments like orthopedics and joint reconstruction, multinational giants like Stryker and Zimmer Biomet command thousands of product variations. In dental care, local leaders Osstem and Shinhung maintain a massive footprint. Vision care (lenses) is dominated by Hoya and Essilor.

Top Device Classifications by Registry Count

The registry is highly diversified, but several specific device types account for a substantial volume of active registrations. The top 5 classifications in the registry by registration count are:

1. Sight Corrective Ophthalmic Lenses: 3,829 active registrations
2. Compression Bandages: 3,731 active registrations
3. General Purpose Splints: 2,814 active registrations
4. Endosseous Dental Implant Superstructures: 2,293 active registrations
5. Manually-Operated Bone Surgical Instruments: 2,209 active registrations

Regulatory Strategic Considerations for Foreign OEMs

For foreign original equipment manufacturers (OEMs) targeting the South Korean market, the registry statistics emphasize several strategic requirements:

1. Choosing the Right Sponsor Model: Because the license is tied directly to the importer of record (ENTP_NAME), changing distributors can be regulatory-intensive. Many high-volume companies establish local subsidiaries (like Stryker Korea) or use independent third-party regulatory sponsors to retain control of their registration assets.
2. Prepare for KGMP Audits: For Risk Grades 2, 3, and 4, manufacturers must pass a Korea Good Manufacturing Practice (KGMP) quality audit. The audit involves a physical inspection of the foreign manufacturing site by an MFDS-authorized third-party auditor, unless a valid MDSAP certificate can be used to mitigate parts of the evaluation.
3. UDI & IMDIS Portal Integration: Beyond registration, South Korea mandates the tracking of devices throughout their distribution lifecycle. Manufacturers must register Unique Device Identification (UDI) details in the MFDS's Integrated Medical Device Information System (IMDIS). Compliance deadlines are fully active across Class I to IV medical devices.
4. DMPA is in force: South Korea's Digital Medical Products Act (DMPA) entered into force on January 24, 2025 (with additional labeling and health-support-device rules taking effect January 24, 2026). For digital medical devices and SaMD, it adds software-specific clinical, validation, and cybersecurity requirements that depart from the traditional hardware pathway — see our complete DMPA compliance guide.

Disclaimer: This article is based on analysis of the public MFDS registry extract. It is intended for educational purposes and does not constitute formal regulatory counseling for specific product compliance.